 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Sep 01, 2005 |
| Title |
CPGSC#25, chip MOE430B |
| Sample type |
RNA |
| |
|
| Source name |
V6.5 (P18), Embryonic
|
| Organism |
Mus musculus |
| Characteristics |
Strain: 129SV x C57Bl/6
|
| Biomaterial provider |
Contact details for sample vendor: V6.5 cell line originally obtained from Dr. R. Jaenesch's lab in Boston
|
| Treatment protocol |
Assays to confirm viability: Stratagene mycoplasma PCR test
|
| Growth protocol |
Growth medium: ES Cell Medium - DMEM(high glucose)
Media supplements: Hyclone FCS (heat inactivated), non-essential amino acids, Glutamax, Penicillin/Streptomycin, beta-mercaptoethanol
Culture conditions: 37 C, 5% CO2
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA prep method: RNeasy
Cell purification method: Cultured
Contaminating cell type: none
|
| Label |
Biotin
|
| |
|
| Description |
This sample was analyzed as part of the Stem Cell Genomics Project (http://www.scgp.ca:8080/StemBase/). The biological material was submitted to the Ontario Genomics Innovation Centre (http://www.ottawagenomecenter.ca/) by Dr. Michael Rudnicki ([email protected]; 501 Smyth Road) for analysis.
Stembase Experiment ID: E113
Stembase Experiment ID link: http://www.scgp.ca:8080/StemBase/?path=/browse/experiment&id=113
SCGP Sample ID: S154
SCGP Sample ID link: http://www.scgp.ca:8080/StemBase/?path=/browse/experiment&id=113#SAMPLE_114
Short description: 6 hours of an 11-point time course study of V6.5 embryonic stem cells and their cognate differentiated embryoid bodies. All samples investigated in triplicate.
Estimated purity: 100%
RNA concentration: 1.45 ug/ul
Num cells for RNA prep: Unable to break up embryoid bodies to do a cell count.
Sample volume: 15 ul
|
| Data processing |
Calculated using the MAS5 algorithm where sc=1500, tau=0.015, alpha1=0.04, and alpla2=0.06
|
| |
|
| Submission date |
Aug 30, 2005 |
| Last update date |
Jan 19, 2006 |
| Organization |
Ottawa Hospital Research Institute |
| Phone |
(613) 737-8899 -73255
|
| Department |
Cellular and Molecular Medicine
|
| Lab |
Ottawa Bioinformatics Core Facility
|
| Street address |
501 Smyth Rd.
|
| City |
Ottawa |
| State/province |
ON |
| ZIP/Postal code |
K1H 8L6 |
| Country |
Canada |
| |
|
| Platform ID |
GPL340 |
| Series (1) |
| GSE3231 |
V6.5 Embryonic Stem Cell and Embryoid Body Time Course |
|
| Data table header descriptions |
| ID_REF |
|
| VALUE |
'signal' a measure of the abundance of a transcript. Calculated using the MAS5 algorithm where sc=1500, tau=0.015, alpha1=0.04, and alpla2=0.06. |
| ABS_CALL |
the call in an absolute analysis that indicates if the transcript was present (P), absent (A), marginal (M), or no call (NC) |
| DETECTION P-VALUE |
'detection p-value', p-value that indicates the significance level of the detection call |
| Data table |
| ID_REF |
VALUE |
ABS_CALL |
DETECTION P-VALUE |
| AFFX-BioB-5_at |
17711.9 |
P |
0.000389797 |
| AFFX-BioB-M_at |
36679.9 |
P |
0.000296708 |
| AFFX-BioB-3_at |
11503.3 |
P |
0.000445901 |
| AFFX-BioC-5_at |
37699.6 |
P |
9.4506e-05 |
| AFFX-BioC-3_at |
26459.3 |
P |
4.42873e-05 |
| AFFX-BioDn-5_at |
26594.2 |
P |
4.42873e-05 |
| AFFX-BioDn-3_at |
190367 |
P |
7.00668e-05 |
| AFFX-CreX-5_at |
338102 |
P |
4.42873e-05 |
| AFFX-CreX-3_at |
507957 |
P |
4.42873e-05 |
| AFFX-DapX-5_at |
102550 |
P |
4.42873e-05 |
| AFFX-DapX-M_at |
252462 |
P |
5.16732e-05 |
| AFFX-DapX-3_at |
379094 |
P |
4.42873e-05 |
| AFFX-LysX-5_at |
26720.9 |
P |
4.42873e-05 |
| AFFX-LysX-M_at |
56416.8 |
P |
5.16732e-05 |
| AFFX-LysX-3_at |
86473.5 |
P |
6.02111e-05 |
| AFFX-PheX-5_at |
11357.1 |
P |
9.4506e-05 |
| AFFX-PheX-M_at |
10938.1 |
P |
0.00010954 |
| AFFX-PheX-3_at |
21332 |
P |
7.00668e-05 |
| AFFX-ThrX-5_at |
5342.31 |
P |
0.000340305 |
| AFFX-ThrX-M_at |
6225.87 |
P |
0.00255552 |
Total number of rows: 22575
Table truncated, full table size 662 Kbytes.
| Supplementary file |
Size |
Download |
File type/resource |
| GSM72813.CEL.gz |
2.8 Mb |
(ftp)(http) |
CEL |
| GSM72813.EXP.gz |
510 b |
(ftp)(http) |
EXP |
|
|
|
|
 |
